Sientra to Report Third Quarter 2020 Financial Results on November 9, 2020

Rhea-AI Summary

Sientra, Inc. (NASDAQ: SIEN) announced it will release its third quarter 2020 financial results on November 9, 2020, post-market close. A conference call is scheduled for the same day at 4:30 p.m. Eastern Time to discuss these results. Domestic callers can dial 844-464-3933, while international callers can use 765-507-2612, with conference ID 6092021. The call will also be available via a live webcast on Sientra's Investor Relations website, which will be archived afterward.

Positive

• The upcoming financial results release indicates transparency and communication with investors.
• The scheduled conference call allows for direct engagement with stakeholders regarding the company's performance.

Negative

• None.

SANTA BARBARA, Calif., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical aesthetics company, today announced that it will release financial results for the third quarter of 2020 after the close of trading on Monday, November 9, 2020. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time.

The dial-in numbers are 844-464-3933 for domestic callers and 765-507-2612 for international callers. The conference ID is 6092021.

A live webcast of the conference call will be available on the Investor Relations section of the Company's website at www.sientra.com. The webcast will be archived on the website following the completion of the call.  

About Sientra
Headquartered in Santa Barbara, California, Sientra is a diversified global medical aesthetics company and a leading partner to aesthetic physicians. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s Breast Products Segment includes its OPUS® breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company’s miraDry Segment, comprised of its miraDry® system, is approved for sale in over 56 international markets and is the only non-surgical, FDA-cleared device indicated for the permanent reduction of underarm sweat and hair and may also reduce odor.

Sientra uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Sientra is routinely posted and is accessible on the Company’s investor relations website at www.sientra.com.

^(*) Data on file

Contact
Investor Relations
805-679-8885

 

FAQ

When will Sientra release its third quarter 2020 financial results?

Sientra will release its third quarter 2020 financial results on November 9, 2020, after market close.

What is the conference call schedule for Sientra's third quarter results?

Sientra will host a conference call on November 9, 2020, at 4:30 p.m. Eastern Time.

How can I access the conference call for Sientra's financial results?

You can dial 844-464-3933 for domestic calls and 765-507-2612 for international calls. The conference ID is 6092021.

Where can I find the archived webcast of Sientra's conference call?

The archived webcast will be available on Sientra's Investor Relations website following the conclusion of the call.

What products does Sientra offer?

Sientra offers a range of medical aesthetics products, including OPUS® breast implants and the miraDry® system for underarm sweat and hair reduction.